Oncolytic Viruses

Crippled Herpesvirus Is Transformed Into A Better Cancer Killer

Published in Cancer Weekly, August 14th, 2001

Scientists have found a way to greatly rev up the cancer-killing ability of a genetically engineered virus, a finding that may eventually lead to more potent anti-cancer therapies that capitalize on the ability of viruses to reproduce in the body.

New York University School of Medicine researchers report in a new study that they have isolated a new version of a herpesvirus that kills cancer cells but spares normal tissue. In animal studies, the new version dramatically reduced the size of human prostate cancer tumors grown in mice. Moreover, it completely eradicated the tumor mass in some of the animals, and it appears not to harm normal tissue.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry